AstraZeneca and Amgen’s TEZSPIRE® Approved for Self-administration in the US
The U.S. Food and Drug Administration (FDA) has approved AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) for self-administration in a pre-filled, single-use
Read moreThe U.S. Food and Drug Administration (FDA) has approved AstraZeneca and Amgen’s TEZSPIRE® (tezepelumab-ekko) for self-administration in a pre-filled, single-use
Read moreThe acquisition agreement is set to expand Aegis’s toxicology portfolio, while HealthTrackRx expands its PCR infectious disease testing. Aegis Sciences
Read moreLonza and Context Therapeutics, a US-based clinical-stage biopharmaceutical company advancing therapeutics for solid tumors, announced that they have reached a
Read moreThermo Fisher Scientific, the global leader in serving science, announced the launch of the TrueMark Infectious Disease Research Panels designed
Read moreFrench clinical-stage biotech company Sensorion, which focuses on the creation of cutting-edge treatments to manage, prevent, and reverse hearing loss
Read morePfizer Inc. (NYSE: PFE) announced in late December, positive top-line results from the Phase 3 BENEGENE-2 study (NCT03861273) evaluating fidanacogene
Read moreModerna Inc will make investments in mRNA research and development (R&D) in the UK and construct a cutting-edge facility for
Read moreThe US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for Novavax’s adjuvanted Covid-19 vaccine, NVX-CoV2373, as
Read moreApogenix, a biopharmaceutical company developing next-gen immunotherapeutics, announced on Wednesday that asunercept showed statistically meaningful benefits for hospitalized COVID-19 patients
Read moreEctica Technologies is delighted to sponsor the 5th Annual Oncology Strategy Meeting organized by Proventa International taking place on May
Read more